ID   PKN3_HUMAN              Reviewed;         889 AA.
AC   Q6P5Z2; Q9UM03;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   05-OCT-2010, entry version 76.
DE   RecName: Full=Serine/threonine-protein kinase N3;
DE            EC=2.7.11.13;
DE   AltName: Full=Protein kinase PKN-beta;
DE   AltName: Full=Protein-kinase C-related kinase 3;
GN   Name=PKN3; Synonyms=PKNBETA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AUTOPHOSPHORYLATION, MUTAGENESIS OF
RP   LYS-588, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=99373159; PubMed=10441506; DOI=10.1006/bbrc.1999.1116;
RA   Oishi K., Mukai H., Shibata H., Takahashi M., Ono Y.;
RT   "Identification and characterization of PKNbeta, a novel isoform of
RT   protein kinase PKN: expression and arachidonic acid dependency are
RT   different from those of PKNalpha.";
RL   Biochem. Biophys. Res. Commun. 261:808-814(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION IN MALIGNANT CELL GROWTH, PHOSPHORYLATION AT THR-718, AND
RP   MUTAGENESIS OF LYS-588 AND THR-718.
RX   PubMed=15282551; DOI=10.1038/sj.emboj.7600345;
RA   Leenders F., Moepert K., Schmiedeknecht A., Santel A., Czauderna F.,
RA   Aleku M., Penschuck S., Dames S., Sternberger M., Roehl T.,
RA   Wellmann A., Arnold W., Giese K., Kaufmann J., Klippel A.;
RT   "PKN3 is required for malignant prostate cell growth downstream of
RT   activated PI 3-kinase.";
RL   EMBO J. 23:3303-3313(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544 AND THR-550, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; THR-508; SER-544;
RP   SER-548; THR-722 AND THR-860, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544 AND SER-548, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544; THR-716 AND
RP   THR-860, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-180.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Contributes to invasiveness in malignant prostate
CC       cancer.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Two specific sites, Thr-718 (activation loop of
CC       the kinase domain) and Thr-860 (turn motif), need to be
CC       phosphorylated for its full activation (By similarity).
CC   -!- INTERACTION:
CC       Q9UNA1:ARHGAP26; NbExp=2; IntAct=EBI-1384335, EBI-1390913;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, perinuclear region.
CC       Note=Nuclear and perinuclear Golgi region.
CC   -!- TISSUE SPECIFICITY: Expressed in prostate tumors and various
CC       cancer cell lines. Not expressed in adult tissues.
CC   -!- DOMAIN: The C1 domain does not bind the diacylglycerol (DAG).
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 3 REM (Hr1) repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB019692; BAA85625.1; -; mRNA.
DR   EMBL; AL441992; CAI15401.1; -; Genomic_DNA.
DR   EMBL; BC062558; AAH62558.1; -; mRNA.
DR   IPI; IPI00413780; -.
DR   PIR; JC7083; JC7083.
DR   RefSeq; NP_037487.2; -.
DR   UniGene; Hs.300485; -.
DR   ProteinModelPortal; Q6P5Z2; -.
DR   SMR; Q6P5Z2; 3-78, 96-166, 181-238, 276-416, 556-889.
DR   IntAct; Q6P5Z2; 11.
DR   MINT; MINT-192027; -.
DR   STRING; Q6P5Z2; -.
DR   PhosphoSite; Q6P5Z2; -.
DR   PRIDE; Q6P5Z2; -.
DR   Ensembl; ENST00000291906; ENSP00000291906; ENSG00000160447.
DR   GeneID; 29941; -.
DR   KEGG; hsa:29941; -.
DR   UCSC; uc004bvw.1; human.
DR   CTD; 29941; -.
DR   GeneCards; GC09P131464; -.
DR   H-InvDB; HIX0034740; -.
DR   HGNC; HGNC:17999; PKN3.
DR   MIM; 610714; gene.
DR   PharmGKB; PA134919098; -.
DR   HOGENOM; HBG387623; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q6P5Z2; -.
DR   OMA; IFSKRRG; -.
DR   OrthoDB; EOG9K9DXJ; -.
DR   PhylomeDB; Q6P5Z2; -.
DR   BRENDA; 2.7.11.13; 247.
DR   NextBio; 52593; -.
DR   ArrayExpress; Q6P5Z2; -.
DR   Bgee; Q6P5Z2; -.
DR   CleanEx; HS_PKN3; -.
DR   Genevestigator; Q6P5Z2; -.
DR   GermOnline; ENSG00000160447; Homo sapiens.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004697; F:protein kinase C activity; IEA:EC.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_Ca-dep.
DR   InterPro; IPR008973; C2_Ca/lipid-bd_dom_CaLB.
DR   InterPro; IPR011072; HR1_rho-bd.
DR   InterPro; IPR000861; HR1_rpt_rho-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Gene3D; G3DSA:1.10.287.160; HR1_rho-bd; 3.
DR   Pfam; PF02185; HR1; 3.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00742; Hr1; 3.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2_CaLB; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF46585; PKN_effector; 3.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    889       Serine/threonine-protein kinase N3.
FT                                /FTId=PRO_0000055725.
FT   REPEAT       18     90       REM 1.
FT   REPEAT      105    181       REM 2.
FT   REPEAT      182    255       REM 3.
FT   DOMAIN      559    818       Protein kinase.
FT   DOMAIN      819    889       AGC-kinase C-terminal.
FT   NP_BIND     565    573       ATP (By similarity).
FT   COMPBIAS    463    554       Pro-rich.
FT   ACT_SITE    684    684       Proton acceptor (By similarity).
FT   BINDING     588    588       ATP (By similarity).
FT   MOD_RES     307    307       Phosphoserine.
FT   MOD_RES     508    508       Phosphothreonine.
FT   MOD_RES     544    544       Phosphoserine.
FT   MOD_RES     548    548       Phosphoserine.
FT   MOD_RES     550    550       Phosphothreonine.
FT   MOD_RES     716    716       Phosphothreonine.
FT   MOD_RES     718    718       Phosphothreonine.
FT   MOD_RES     722    722       Phosphothreonine.
FT   MOD_RES     860    860       Phosphothreonine.
FT   VARIANT     180    180       A -> E (in dbSNP:rs56251280).
FT                                /FTId=VAR_042346.
FT   VARIANT     404    404       V -> L (in dbSNP:rs12932).
FT                                /FTId=VAR_050565.
FT   MUTAGEN     588    588       K->E: Abolishes autophosphorylation and
FT                                catalytic activity.
FT   MUTAGEN     588    588       K->R: Abolishes catalytic activity.
FT   MUTAGEN     718    718       T->A: Abolishes phosphorylation.
FT   CONFLICT    444    444       A -> R (in Ref. 1; BAA85625).
FT   CONFLICT    627    627       A -> V (in Ref. 1; BAA85625).
FT   CONFLICT    636    636       C -> R (in Ref. 1; BAA85625).
FT   CONFLICT    738    738       R -> Q (in Ref. 1; BAA85625).
FT   CONFLICT    744    744       G -> A (in Ref. 1; BAA85625).
SQ   SEQUENCE   889 AA;  99421 MW;  F3891DA1420DF54E CRC64;
     MEEGAPRQPG PSQWPPEDEK EVIRRAIQKE LKIKEGVENL RRVATDRRHL GHVQQLLRSS
     NRRLEQLHGE LRELHARILL PGPGPGPAEP VASGPRPWAE QLRARHLEAL RRQLHVELKV
     KQGAENMTHT CASGTPKERK LLAAAQQMLR DSQLKVALLR MKISSLEASG SPEPGPELLA
     EELQHRLHVE AAVAEGAKNV VKLLSSRRTQ DRKALAEAQA QLQESSQKLD LLRLALEQLL
     EQLPPAHPLR SRVTRELRAA VPGYPQPSGT PVKPTALTGT LQVRLLGCEQ LLTAVPGRSP
     AAALASSPSE GWLRTKAKHQ RGRGELASEV LAVLKVDNRV VGQTGWGQVA EQSWDQTFVI
     PLERARELEI GVHWRDWRQL CGVAFLRLED FLDNACHQLS LSLVPQGLLF AQVTFCDPVI
     ERRPRLQRQE RIFSKRRGQD FLRASQMNLG MAAWGRLVMN LLPPCSSPST ISPPKGCPRT
     PTTLREASDP ATPSNFLPKK TPLGEEMTPP PKPPRLYLPQ EPTSEETPRT KRPHMEPRTR
     RGPSPPASPT RKPPRLQDFR CLAVLGRGHF GKVLLVQFKG TGKYYAIKAL KKQEVLSRDE
     IESLYCEKRI LEAVGCTGHP FLLSLLACFQ TSSHACFVTE FVPGGDLMMQ IHEDVFPEPQ
     ARFYVACVVL GLQFLHEKKI IYRDLKLDNL LLDAQGFLKI ADFGLCKEGI GFGDRTSTFC
     GTPEFLAPEV LTQEAYTRAV DWWGLGVLLY EMLVGECPFP GDTEEEVFDC IVNMDAPYPG
     FLSVQGLEFI QKLLQKCPEK RLGAGEQDAE EIKVQPFFRT TNWQALLART IQPPFVPTLC
     GPADLRYFEG EFTGLPPALT PPAPHSLLTA RQQAAFRDFD FVSERFLEP
//
